Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine intraperitoneal instillation versus TAP block for postoperative analgesia after laparoscopic cholecystectomy
IRCT20190511043550N4Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ropivacaine in postoperative pain (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Postoperative pain. Started Feb 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20190511043550N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190511043550N4.